Ivanova, A., Von Ahsen, N., Adjarov, D., Krastev, Z., Oellerich, M., Wieland, E.
C282Y and H63D mutations in the HFE gene are not associated with porphyria cutanea tarda in Bulgaria [3]
(1999) Hepatology, 30 (6), pp. 1531-1532. Cited 20 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0032721834&partnerID=40&md5=9cd17577e69f5613db5f9c7db09c78ca
DOCUMENT TYPE: Letter
SOURCE: Scopus
Jalil, S., Grady, J.J., Lee, C., Anderson, K.E.
Associations Among Behavior-Related Susceptibility Factors in Porphyria Cutanea Tarda
(2010) Clinical Gastroenterology and Hepatology, 8 (3), pp. 297-302.e1.
http://www.scopus.com/inward/record.url?eid=2-s2.0-77349089994&partnerID=40&md5=5706bab3e33c8552ad6d33d03ed84019
DOCUMENT TYPE: Article
SOURCE: Scopus
Alkhateeb, A., Uzrail, A., Bodoor, K.
Frequency of the hemochromatosis gene (HFE) variants in a Jordanian Arab population and in diabetics from the same region
(2009) Disease Markers, 27 (1), pp. 17-22.
http://www.scopus.com/inward/record.url?eid=2-s2.0-70350495648&partnerID=40&md5=a28c2de491538b67efe1d10ac6c8d2c9
DOCUMENT TYPE: Article
SOURCE: Scopus
Voicu, P.-M., Cojocariu, C., Petrescu-Danila, E., Covic, M., Stanciu, C., Rusu, M.
Prevalence of HFE (hemochromatosis) gene mutations C282Y and H63D in a Romanian population
(2009) Blood Cells, Molecules, and Diseases, 42 (1), pp. 14-15.
http://www.scopus.com/inward/record.url?eid=2-s2.0-57949101660&partnerID=40&md5=0c3554ef9acb10ab429a68258f49d7ab
DOCUMENT TYPE: Letter
SOURCE: Scopus
Cribier, B., Chiaverini, C., Dali-Youcef, N., Schmitt, M., Grima, M., Hirth, C., Lacour, J.-P., Chosidow, O.
Porphyria cutanea tarda, hepatitis C, uroporphyrinogen decarboxylase and mutations of HFE gene: A case-control study
(2008) Dermatology, 218 (1), pp. 15-21. Cited 1 time.
http://www.scopus.com/inward/record.url?eid=2-s2.0-58149096779&partnerID=40&md5=a9b0ba73cd29c221ea6c82032fcadfe5
DOCUMENT TYPE: Article
SOURCE: Scopus
Kratka, K., Dostalikova-Cimburova, M., Michalikova, H., Stransky, J., Vranova, J., Horak, J.
High prevalence of HFE gene mutations in patients with porphyria cutanea tarda in the Czech Republic
(2008) British Journal of Dermatology, 159 (3), pp. 585-590. Cited 3 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-49749085911&partnerID=40&md5=8cb97a019c77f85db069dcd04a3cffb1
DOCUMENT TYPE: Article
SOURCE: Scopus
Frank, J., Poblete-Gutiérrez, P., Weiskirchen, R., Gressner, O., Merk, H.F., Lammert, F.
Hemochromatosis gene sequence deviations in German patients with porphyria cutanea tarda
(2006) Physiological Research, 55 (SUPPL. 2), pp. S75-S83. Cited 5 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-33847100568&partnerID=40&md5=e54d49d22140157cb65131b5be0690f8
DOCUMENT TYPE: Article
SOURCE: Scopus
Šarić, M., Zamurović, Lj., Keckarević-Marković, M., Keckarević, D., Stevanović, M., Savić-Pavićević, D., Jović, J., Romac, S.
Frequency of the hemochromatosis gene mutations in the population of Serbia and Montenegro [2]
(2006) Clinical Genetics, 70 (2), pp. 170-172. Cited 3 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-33745870875&partnerID=40&md5=3d1959a742d014223f1f557cebf0d7c1
DOCUMENT TYPE: Letter
SOURCE: Scopus
Nagy, Z., Kószo, F., Pár, A., Emri, G., Horkay, I., Horányi, M., Karádi, O., Rumi Jr., G., Morvay, M., Varga, V., Dobozy, A., Mózsik, G.
Hemochromatosis (HFE) gene mutations and hepatitis C virus infection as risk factors for porphyria cutanea tarda in Hungarian patients
(2004) Liver International, 24 (1), pp. 16-20. Cited 8 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-12144287994&partnerID=40&md5=2068520e0d480bf14304e1853e228172
DOCUMENT TYPE: Article
SOURCE: Scopus
Lucotte, G., Dieterlen, F.
A European allele map of the C282Y mutation of hemochromatosis: Celtic versus Viking origin of the mutation?
(2003) Blood Cells, Molecules, and Diseases, 31 (2), pp. 262-267. Cited 23 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0346753577&partnerID=40&md5=b7d1cfaa660c17907f80bc7ac080108c
DOCUMENT TYPE: Article
SOURCE: Scopus
Milman, N., Pedersen, P.
Evidence that the Cys282Tyr mutation of the HFE gene originated from a population in Southern Scandinavia and spread with the Vikings
(2003) Clinical Genetics, 64 (1), pp. 36-47. Cited 45 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0042131687&partnerID=40&md5=30448b6ad8c3d1dea97754f9de7f43b9
DOCUMENT TYPE: Article
SOURCE: Scopus
Stölzel, U., Köstler, E., Schuppan, D., Richter, M., Wollina, U., Doss, M.O., Wittekind, C., Tannapfel, A.
Hemochromatosis (HFE) gene mutations and response to chloroquine in porphyria Cutanea tarda
(2003) Archives of Dermatology, 139 (3), pp. 309-313. Cited 27 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0037341145&partnerID=40&md5=3ca72516934d3f76f9d5284bab3fb8db
DOCUMENT TYPE: Article
SOURCE: Scopus
Malina, L., Ždárský, E., Stránský, J., Dandová, S., Michalíková, H.
Are hepatitis C infection and C282Y mutation in hemochromatosis gene independent factors for porphyria cutanea tarda? [5]
(2002) Dermatology, 205 (1), pp. 76-77. Cited 3 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0036979252&partnerID=40&md5=97dc67dd95d4cbb745e1c30e96d145e0
DOCUMENT TYPE: Letter
SOURCE: Scopus
Egger, N.G., Goeger, D.E., Payne, D.A., Miskovsky, E.P., Weinman, S.A., Anderson, K.E.
Porphyria cutanea tarda: Multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency
(2002) Digestive Diseases and Sciences, 47 (2), pp. 419-426. Cited 35 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0036164415&partnerID=40&md5=0883ac2931df7a57d40a19fd88033c2e
DOCUMENT TYPE: Article
SOURCE: Scopus
Tannapfel, A., Stölzel, U., Köstler, E., Melz, S., Richter, M., Keim, V., Schuppan, D., Wittekind, C.
C282Y and H63D mutation of the hemochromatosis gene in German porphyria cutanea tarda patients
(2001) Virchows Archiv, 439 (1), pp. 1-5. Cited 34 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0034923034&partnerID=40&md5=e828af8bfd799a621cc8b866bd0b68f6
DOCUMENT TYPE: Article
SOURCE: Scopus
Lucotte, G.
Frequency analysis and allele map in favor of the celtic origin of the c282y mutation of hemochromatosis
(2001) Blood Cells, Molecules, and Diseases, 27 (2), pp. 549-556. Cited 28 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0034976902&partnerID=40&md5=3571b110593dea6be2009ae828871e78
DOCUMENT TYPE: Conference Paper
SOURCE: Scopus
Dereure, O., Aguilar-Martinez, P., Bessis, D., Perney, P., Vallat, C., Guillot, B., Blanc, F., Guilhou, J.-J.
HFE mutations and transferrin receptor polymorphism analysis in porphyria cutanea tarda: A prospective study of 36 cases from southern France
(2001) British Journal of Dermatology, 144 (3), pp. 533-539. Cited 26 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0035087466&partnerID=40&md5=83b0e9646d4363ca2c0473483acfa0fc
DOCUMENT TYPE: Article
SOURCE: Scopus
Sinclair, P.R., Gorman, N., Walton, H.S., Bement, W.J., Sinclair, J.F., Gerhard, G.S., Szakacs, J.G., Andrews, N.C., Levy, J.E.
Uroporphyria in Hfe mutant mice given 5-aminolevulinate: A new model of Fe-mediated porphyria cutanea tarda
(2001) Hepatology, 33 (2), pp. 406-412. Cited 16 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0035143860&partnerID=40&md5=1e1ab20a612ca658084847be5faadecf
DOCUMENT TYPE: Article
SOURCE: Scopus
Dhumeaux, D., Hezode, C.
Iron overload and liver diseases (except for hemochromatosis and dysmetabolic hepatosiderosis) [Surcharges en fer et hépatopathies (en dehors de l'hémochromatose et de l'hépatosidérose dysmétabolique)]
(2000) Bulletin de l'Academie Nationale de Medecine, 184 (2), pp. 349-354. Cited 1 time.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0348003138&partnerID=40&md5=3613d9de0583633ca0937227f7e17fa9
DOCUMENT TYPE: Article
SOURCE: Scopus
Brady, J.J., Jackson, H.A., Roberts, A.G., Morgan, R.R., Whatley, S.D., Rowlands, G.L., Darby, C., Shudell, E., Watson, R., Paiker, J., Worwood, M.W., Elder, G.H.
Co-inheritance of mutations in the uroporphyrinogen decarboxylase and hemochromatosis genes accelerates the onset of porphyria cutanea tarda
(2000) Journal of Investigative Dermatology, 115 (5), pp. 868-874. Cited 36 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0033739090&partnerID=40&md5=9defd3543467f7166ebc67d8615d72d0
DOCUMENT TYPE: Article
SOURCE: Scopus
Merryweather-Clarke, A.T., Pointon, J.J., Jouanolle, A.M., Rochette, J., Robson, K.J.H.
Geography of HFE C282Y and H63D mutations
(2000) Genetic Testing, 4 (2), pp. 183-198. Cited 146 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0033862319&partnerID=40&md5=2de97946b5073959a4f02f141fdbc81c
DOCUMENT TYPE: Article
SOURCE: Scopus
Boyanova, L., Spassova, Z., Krastev, Z., Petrov, S., Stancheva, I., Docheva, J., Mitov, I., Koumanova, R.
Characteristics and trends in macrolide resistance among Helicobacter pylori strains isolated in Bulgaria over four years
(1999) Diagnostic Microbiology and Infectious Disease, 34 (4), pp. 309-313. Cited 17 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0032784554&partnerID=40&md5=c16f1f18ed902b794d599687c1e3839f
DOCUMENT TYPE: Article
SOURCE: Scopus
Taneike, I., Nami, A., O'Connor, A., Fitzgerald, N., Murphy, P., Qasim, A., O'Connor, H., O'Morain, C.
Analysis of drug resistance and virulence-factor genotype of Irish Helicobacter pylori strains: Is there any relationship between resistance to metronidazole and cagA status?
(2009) Alimentary Pharmacology and Therapeutics, 30 (7), pp. 784-790.
http://www.scopus.com/inward/record.url?eid=2-s2.0-69949156383&partnerID=40&md5=36031145bfb1ae23f9195115aa6c3898
DOCUMENT TYPE: Article
SOURCE: Scopus
Lü, L., Mei, Z.-C.
The mechanism and detection of Helicobacter pylori resistance to macrolides
(2007) Chinese Journal of Antibiotics, 32 (1), pp. 6-10+16. Cited 2 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-34047192639&partnerID=40&md5=5f64d078040ac85304a0808d6066e81a
DOCUMENT TYPE: Article
SOURCE: Scopus
Di Mario, F., Cavallaro, L.G., Scarpignato, C.
'Rescue' therapies for the management of Helicobacter pylori infection
(2006) Digestive Diseases, 24 (1-2), pp. 113-130. Cited 21 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-33644537268&partnerID=40&md5=e59ac63b279c5cf251929295d6a93649
DOCUMENT TYPE: Review
SOURCE: Scopus
Mégraud, F.
H pylori antibiotic resistance: Prevalence, importance, and advances in testing
(2004) Gut, 53 (9), pp. 1374-1384. Cited 176 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-4344592305&partnerID=40&md5=5bfac4b14ed4e8a1327fe91a0b84458a
DOCUMENT TYPE: Review
SOURCE: Scopus
Masuda, H., Hiyama, T., Yoshihara, M., Tanaka, S., Haruma, K., Chayama, K.
Characteristics and trends of clarithromycin-resistant Helicobacter pylori isolates in Japan over a decade
(2004) Pathobiology, 71 (3), pp. 159-163. Cited 13 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-1842508149&partnerID=40&md5=8682429a5333f163438d43d09f814ac8
DOCUMENT TYPE: Article
SOURCE: Scopus
Toracchio, S., Marzio, L.
Primary and secondary antibiotic resistance of Helicobacter pylori strains isolated in central Italy during the years 1998-2002
(2003) Digestive and Liver Disease, 35 (8), pp. 541-545. Cited 65 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-2142774070&partnerID=40&md5=6d8b6d9da9dcd78c0ae14ee75e08e108
DOCUMENT TYPE: Article
SOURCE: Scopus
Taneike, I., Goshi, S., Tamura, Y., Wakisaka-Saito, N., Matsumori, N., Yanase, A., Shimizu, T., Yamashiro, Y., Toyoda, S., Yamamoto, T.
Emergence of clarithromycin-resistant Helicobacter pylori (CRHP) with a high prevalence in children compared with their parents
(2002) Helicobacter, 7 (5), pp. 297-305. Cited 13 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-18644365083&partnerID=40&md5=50962b434728acd1a6553f258daa306b
DOCUMENT TYPE: Article
SOURCE: Scopus
Wolle, K., Leodolter, A., Malfertheiner, P., König, W.
Antibiotic susceptibility of Helicobacter pylori in Germany: Stable primary resistance from 1995 to 2000
(2002) Journal of Medical Microbiology, 51 (8), pp. 705-709. Cited 49 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0036071258&partnerID=40&md5=f3ae9dedee9f82d9b086fe19fd782140
DOCUMENT TYPE: Article
SOURCE: Scopus
Gold, B.D.
Helicobacter pylori infection in children
(2001) Current Problems in Pediatrics, 31 (8), pp. 247-266. Cited 4 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0035212841&partnerID=40&md5=2f097249821b3fa9f916012a6a526c81
DOCUMENT TYPE: Article
SOURCE: Scopus
Parsons, H.K., Carter, M.J., Sanders, D.S., Winstanley, T., Lobo, A.J.
Helicobacter pylori antimicrobial resistance in the United Kingdom: The effect of age, sex and socio-economic status
(2001) Alimentary Pharmacology and Therapeutics, 15 (9), pp. 1473-1478. Cited 29 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0034845655&partnerID=40&md5=42978cfe52e24c1c5dac89ee583f135f
DOCUMENT TYPE: Article
SOURCE: Scopus
Osato, M.S., Reddy, R., Reddy, S.G., Penland, R.L., Malaty, H.M., Graham, D.Y.
Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States
(2001) Archives of Internal Medicine, 161 (9), pp. 1217-1220. Cited 85 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0034925027&partnerID=40&md5=a7e17e1766d015698f056f5b40c0fa5c
DOCUMENT TYPE: Article
SOURCE: Scopus
Rhomberg, P.R., Biedenbach, D.J., Jones, R.N.
Activity of BMS284756 (T-3811) tested against anaerobic bacteria, Campylobacter jejuni, Helicobacter pylori and Legionella spp.
(2001) Diagnostic Microbiology and Infectious Disease, 40 (1-2), pp. 45-49. Cited 15 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0034969497&partnerID=40&md5=3eaa8f3b3eb2751d7409e63ee33d610f
DOCUMENT TYPE: Article
SOURCE: Scopus
Williamson, J.S.
Helicobacter pylori: Current chemotherapy and new targets for drug design
(2001) Current Pharmaceutical Design, 7 (5), pp. 355-392. Cited 10 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0035042448&partnerID=40&md5=f4212d023186ad37c14602dcd2d90845
DOCUMENT TYPE: Article
SOURCE: Scopus
Osato, M.S., Reddy, S.G., Piergies, A.A., Bochenek, W.J., Testa, R.T., Graham, D.Y.
Comparative efficacy of new investigational agents against Helicobacter pylori
(2001) Alimentary Pharmacology and Therapeutics, 15 (4), pp. 487-492. Cited 16 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0035075226&partnerID=40&md5=3996ca4ada31d0b2f556ac029382b6dc
DOCUMENT TYPE: Article
SOURCE: Scopus
Cantón, R., Martín de Argila, C., De Rafael, L., Baquero, F.
Antimicrobial resistance in Helicobacter pylori
(2001) Reviews in Medical Microbiology, 12 (1), pp. 47-61. Cited 4 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0035139088&partnerID=40&md5=cdc3fe5829204ce436247c088ec8914d
DOCUMENT TYPE: Article
SOURCE: Scopus
García Díaz, E., Romero Gómez, M., Vargas, J., Guil, A., Bernal, S., Castro, M.
Prevalence and clinical significance of antibiotic resistance in Helicobacter pylori [Prevalencia y significado clínico de resistencia antibiótica de Helicobacter pylori]
(2000) Revista Espanola de Enfermedades Digestivas, 92 (10), pp. 651-660. Cited 1 time.
http://www.scopus.com/inward/record.url?eid=2-s2.0-8844224900&partnerID=40&md5=6ee125a963780597406b56ccb8d6a714
DOCUMENT TYPE: Article
SOURCE: Scopus
Gold, B.D.
Helicobacter pylori infection in children
(1999) Current Problems in Pediatric and Adolescent Health Care, 31 (8), pp. 247-266. Cited 7 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0039299810&partnerID=40&md5=81672a7f0271c8ecee408521fb0cb2b9
DOCUMENT TYPE: Article
SOURCE: Scopus
Krastev, Z., Antonov, K., Vassilev, M., Jelev, D.
Treatment with low-dose interferon-alpha in bulgarian HBeAg-negative patients with chronic hepatitis B [1]
(1998) Journal of Clinical Gastroenterology, 27 (4), pp. 367-368. Cited 1 time.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0031732615&partnerID=40&md5=2a39e666f758e7912147f3e9b1eb7f52
DOCUMENT TYPE: Letter
SOURCE: Scopus
Krastev, Z.A.
The "return" of hepatitis B
(2006) World Journal of Gastroenterology, 12 (44), pp. 7081-7086. Cited 8 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-33845423659&partnerID=40&md5=03d062c0e49d8a46bde330c493899715
DOCUMENT TYPE: Editorial
SOURCE: Scopus
Krastev, Z.
Liver Damage Score - A new index for evaluation of the severity of chronic liver diseases
(1998) Hepato-Gastroenterology, 45 (19), pp. 160-169. Cited 1 time.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0031937315&partnerID=40&md5=a0b11fbe6d7913e45fd25214f7457765
DOCUMENT TYPE: Article
SOURCE: Scopus
Yu, R.-S., Hao, L., Dong, F., Mao, J.-S., Sun, J.-Z., Chen, Y., Lin, M., Wang, Z.-K., Ding, W.-H.
Biochemical metabolic changes assessed by 31P magnetic resonance spectroscopy after radiation-induced hepatic injury in rabbits
(2009) World Journal of Gastroenterology, 15 (22), pp. 2723-2730.
http://www.scopus.com/inward/record.url?eid=2-s2.0-67651149749&partnerID=40&md5=fc5b6bbdd18ffaca7286aad8110e4680
DOCUMENT TYPE: Article
SOURCE: Scopus
Matov, V., Metchkov, G., Krastev, Z., Tchernev, K., Mitova, R., Márquez, M., Torres, J., Herrero, E., Fillat, O., Ortiz, J.A.
Ebrotidine versus ranitidine in the treatment of acute duodenal ulcer: A multicentre, randomized, double-blind, controlled clinical trial
(1997) Arzneimittel-Forschung/Drug Research, 47 (4 A SPEC. ISSUE), pp. 555-559. Cited 4 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-8244247775&partnerID=40&md5=2bc5e42ae7e0299adf7b296ca226a01a
DOCUMENT TYPE: Article
SOURCE: Scopus
Scarpignato, C., Pelosini, I., Di Mario, F.
Acid suppression therapy: Where do we go from here?
(2006) Digestive Diseases, 24 (1-2), pp. 11-46. Cited 28 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-33646732206&partnerID=40&md5=6b61d89ddd4ad0b0eb61100c7c9038e3
DOCUMENT TYPE: Review
SOURCE: Scopus
Annapurna, A., Kumar, V.K., Rajasekhar, J., Srinivas, A.U.
Ebrotidine: A novel H2-receptor antagonist
(2001) Indian Drugs, 38 (3), pp. 114-121.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0034948403&partnerID=40&md5=eff92b6a380afed257aa8979f8596203
DOCUMENT TYPE: Review
SOURCE: Scopus
Aníbarro, P.C., Carmona, J.B., González, F.G., Sotillos, M.G., Gil, D.H., Giménez, R.P., Picón, S.J.
Allergic dermatitis due to oral ebrotidine
(1999) Journal of Investigational Allergology and Clinical Immunology, 9 (3), pp. 193-194. Cited 1 time.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0345189541&partnerID=40&md5=c5fda7f8d6830993e4f8c2da3b173e6a
DOCUMENT TYPE: Article
SOURCE: Scopus
Ebrotidine Ebrocit(R): Gastric antisecretory H2-Receptor antagonist
(1998) Drugs of the Future, 23 (2), pp. 214-217.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0031943278&partnerID=40&md5=dcfdf51d37e941acfa6bd67aa4308fb9
DOCUMENT TYPE: Short Survey
SOURCE: Scopus
Antonov, K., Krastev, Z., Teoharov, P., Zaharieva, E., Alexiev, A., Ivanova, A., Adjarov, D.
Hepatitis C virus infection: A possible promoting agent in porphyria cutanea tarda
(1996) Italian Journal of Gastroenterology, 28 (9), pp. 482-486. Cited 6 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0030430279&partnerID=40&md5=13b1cb4139e05f65ace73ac50ea886d1
DOCUMENT TYPE: Article
SOURCE: Scopus
Gisbert, J.P., García-Buey, L., Pajares, J.M., Moreno-Otero, R.
Prevalence of hepatitis C virus infection in porphyria cutanea tarda: Systematic review and meta-analysis
(2003) Journal of Hepatology, 39 (4), pp. 620-627. Cited 42 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0141674800&partnerID=40&md5=7052a9a1e014744305af6f04731b71dc
DOCUMENT TYPE: Review
SOURCE: Scopus
Ma, Y., Fracanzani, A.L., Sampietro, M., Mattioli, M., Cheeseman, P., Williams, R., Mieli-Vergani, G., Vergani, D., Fargion, S.
Autoantibodies to human cytosol: A marker of sporadic porphyria cutanea tarda
(2001) Clinical and Experimental Immunology, 126 (1), pp. 47-53. Cited 4 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0034771291&partnerID=40&md5=03c13cd1a65eefc973a22d8a3d907acc
DOCUMENT TYPE: Article
SOURCE: Scopus
Gibson, P.R., Grant, J., Cronin, V., Blake, D., Ratnaike, S.
Effect of hepatobiliary disease, chronic hepatitis C and hepatitis B virus infections and interferon-α on porphyrin profiles in plasma, urine and faeces
(2000) Journal of Gastroenterology and Hepatology, 15 (2), pp. 192-201. Cited 9 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0034102979&partnerID=40&md5=00a79d46d67a1c46f42352c95b1bee2d
DOCUMENT TYPE: Article
SOURCE: Scopus
Degos, F.
Hepatitis C and alcohol
(1999) Journal of Hepatology, Supplement, 31 (1), pp. 113-118. Cited 49 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0033406306&partnerID=40&md5=7acb01d73b5610da945173d8e3d81cd2
DOCUMENT TYPE: Conference Paper
SOURCE: Scopus
Dohmen, K., Onohara, S., Ajibe, H., Shikahama, M., Miyamoto, Y., Irie, K., Ishibashi, H.
Chronic hepatitis C associated with porphyria cutanea tarda which showed hepatic focal fatty change arising in a non-alcoholic patient
(1999) Acta Hepatologica Japonica, 40 (6), pp. 350-354.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0032802272&partnerID=40&md5=5cf00880f2361e0e53eeec7d70ee6934
DOCUMENT TYPE: Article
SOURCE: Scopus
Rivanera, D., Lilli, D., Griso, D., Macrì, A., Mancini, C.
Hepatitis C virus in patients with porphyria cutanea tarda: Relationship to HCV-genotypes
(1998) New Microbiologica, 21 (4), pp. 329-334. Cited 10 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0032176120&partnerID=40&md5=0accae697e425ebe6da2b9d95de427b7
DOCUMENT TYPE: Article
SOURCE: Scopus
Сподели с приятели: |